Skip to content

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Amgen logo
AmgenAMGN
2.8B0.0%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1K0.0%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$11K+22.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
500M0.0%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.21B+475%
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s common stock?
MBX Biosciences, Inc. (MBX) reported common stock of $6K in Q1 2026.
How has MBX Biosciences, Inc.'s common stock changed year-over-year?
MBX Biosciences, Inc.'s common stock increased by 20.0% year-over-year, from $5K to $6K.
What is the long-term trend for MBX Biosciences, Inc.'s common stock?
Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s common stock has grown at a 144.9% compound annual growth rate (CAGR), from $1K to $6K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).